MAHA: What’s Real, What's Fake, What's Unclear? ft. Cremieux
The Charlie Kirk Show
00:00
Navigating Affirmative Action and Pharmaceutical Innovation
This chapter explores the complexities of affirmative action in Harvard's admissions, contrasting requirements for different racial groups and examining legacy admissions' impact. It also discusses the challenges in pharmaceutical research funding, the effects of over-regulation, and the balance between innovation and foreign investment in American biotech. The conversation raises critical questions about the direction of funding in hard sciences and the impact of societal ideologies on research priorities.
Transcript
Play full episode
